A 62 year old male came with a chief complaint of disorientation , altered sensorium. One day history of fever and running nose. No headache or vomitings. Known diabetic and hypertension. No substance abuse. Ct brain is normal. Blood picture, electrolytes to be done.
acute encephalopathy altered mental status fever elderly
delirium fever diabetes altered consciousness
| Diagnosis | Why it fits | Key pointer |
|---|---|---|
| Hyperosmolar Hyperglycemic State (HHS) | Elderly T2DM, viral illness (URTI) precipitant, no vomiting, altered consciousness | Blood glucose, osmolality |
| Diabetic Ketoacidosis (DKA) | Known DM, fever/infection as precipitant | Glucose, ABG, ketones, anion gap |
| Septic Encephalopathy | Fever + confusion in elderly; 70% of bacteremic patients develop confusional state, most often the "quiet" (hypoactive) type | Blood culture, CRP, procalcitonin, CBC |
| Hyponatremia / Electrolyte disturbance | Hypertensive patients often on thiazides/ACE inhibitors; URTI with poor intake → hyponatremia | Na, K, Ca, Mg, osmolality |
| Urinary Tract Infection / Occult Sepsis | Common silent precipitant in elderly, especially diabetics | Urine microscopy & culture |
| Diagnosis | Why consider |
|---|---|
| Hypoglycemia | Known diabetic on medication; can mimic any neurological picture — check immediately at bedside |
| Viral encephalitis | 1-day fever, URTI prodrome (e.g., HSV, enterovirus, influenza) — no headache/vomiting reduces probability but doesn't exclude |
| Hypertensive encephalopathy / Pposterior Reversible Encephalopathy Syndrome (PRES) | Known hypertension, CT brain may be normal (PRES is best seen on MRI FLAIR) |
| Meningitis (bacterial/viral) | Absence of headache/neck stiffness lowers probability but LP may still be warranted if no clear etiology found |
| Nonconvulsive Status Epilepticus (NCSE) | Can present as "quiet confusion" with no motor signs; CT is normal; EEG required |
| Acute renal failure/uremia | Diabetic nephropathy + dehydration |
"The most frequent causes of global confusional states in general practice are drug intoxications and endogenous metabolic encephalopathies, mainly electrolyte and water imbalance, renal and hepatic failure, hyper- and hypoglycemia, febrile and septic states." — Adams and Victor's Principles of Neurology, 12th Ed.
| Investigation | Rationale |
|---|---|
| Random blood glucose | DKA / HHS |
| Serum electrolytes (Na, K, Cl, HCO₃) | Hypo/hypernatremia, anion gap |
| Serum osmolality | HHS (>320 mOsm/kg) |
| ABG | DKA (pH <7.3), respiratory failure, CO₂ retention |
| Complete Blood Count (CBC) | Leukocytosis → infection/sepsis |
| Blood urea, creatinine | Renal failure (uremic encephalopathy) |
| Serum ketones / urine ketones | DKA |
| Liver function tests | Hepatic encephalopathy |
| Serum calcium, magnesium | Electrolyte encephalopathy |
| Thyroid function (TSH) | Myxedema/thyroid storm |
| Blood culture × 2 | Bacteremia / sepsis |
| HbA1c | Degree of glycemic control |
| Serum lactate | Sepsis, metformin-associated lactic acidosis |
| Test | Indication |
|---|---|
| Chest X-ray | Pneumonia as sepsis source |
| MRI Brain (FLAIR/DWI) | If no metabolic cause found — rules out PRES, early ischemia, encephalitis |
| Lumbar Puncture | If fever persists with no metabolic explanation, or encephalitis/meningitis suspected |
| EEG | If NCSE suspected (no motor convulsions but persistent confusion) |
Treatment if suspicion is encephalitis. Blood glucose is initially 110 , then 70 .
⚠️ Do NOT wait — treat the hypoglycemia NOW, regardless of the encephalitis workup. Hypoglycemia is reversible within minutes; encephalitic damage from delayed treatment is not.
The altered sensorium may be partly or entirely due to hypoglycemia — reassess mental status after correction before attributing all symptoms to encephalitis.
"Early treatment of herpes simplex encephalitis is vital as treatment with acyclovir yields the best results when administered before patients become comatose. Most patients with suspected herpes encephalitis are now treated immediately, with the drug discontinued later if the diagnosis is not confirmed." — Plum and Posner's Diagnosis and Treatment of Stupor and Coma
| Action | Detail |
|---|---|
| ABC assessment | Secure airway if GCS ≤8; SpO₂ monitoring |
| IV access × 2 | Large-bore peripheral lines |
| Treat hypoglycemia | As above — glucose to 140–180 |
| Vitals monitoring | BP, HR, temp, SpO₂ continuous |
| Seizure precautions | Bed rails up, O₂ at bedside |
| Drug | Dose | Duration |
|---|---|---|
| IV Acyclovir | 10 mg/kg every 8 hours | 14–21 days (21 days for confirmed HSV) |
| CrCl (mL/min) | Acyclovir dose adjustment |
|---|---|
| >50 | 10 mg/kg q8h (full dose) |
| 25–50 | 10 mg/kg q12h |
| 10–25 | 10 mg/kg q24h |
| <10 / dialysis | 5 mg/kg q24h |
"The alkaline pH of acyclovir can cause local inflammation and phlebitis. Dose adjustment is required in patients with impaired renal glomerular filtration. Penetration into CSF is excellent." — Harrison's Principles of Internal Medicine, 22nd Ed.
| Drug | Dose | Indication |
|---|---|---|
| IV Ceftriaxone | 2 g every 12 hours | Bacterial meningitis coverage |
| IV Dexamethasone | 0.15 mg/kg q6h × 4 days | Start before/with first antibiotic dose — reduces neurological sequelae in bacterial meningitis |
Stop ceftriaxone and dexamethasone if CSF/cultures confirm viral etiology.
| Concern | Management |
|---|---|
| Raised ICP | Head of bed 30°, fluid restriction, avoid hypotonic fluids, mannitol if herniation signs |
| Seizures | Levetiracetam (preferred in metabolic patients) or phenytoin; prophylaxis warranted |
| Fever | Paracetamol IV; active cooling if >40°C |
| Aspiration risk | NPO if GCS altered; NG tube for medications/feeds |
| DVT prophylaxis | LMWH + compression stockings |
| Glycemic control | Target glucose 140–180 mg/dL; insulin infusion if needed; avoid hypoglycemia |
| Blood pressure | Cautious control — avoid abrupt drops (cerebral perfusion pressure) |
| Condition | Outcome |
|---|---|
| HSV encephalitis — treated early (before coma) | Mortality ~10%, good recovery possible |
| HSV encephalitis — treated late (comatose) | Mortality 70%+ untreated; high disability even treated |
| Post-HSV autoimmune encephalitis | Can occur 1–7 weeks later (NMDA-R antibodies) — watch for relapse |
1. D50W 25 mL IV STAT → recheck glucose in 15 min → 10% Dextrose infusion
2. IV Acyclovir 10 mg/kg (adjusted for renal function) q8h — START NOW
3. IV Ceftriaxone 2g q12h + IV Dexamethasone 0.15 mg/kg q6h
4. Lumbar puncture (HSV PCR, cell count, glucose, protein, culture)
5. MRI Brain with FLAIR/DWI/Gadolinium
6. EEG
7. ICU admission / HDU monitoring
8. Check renal function, LFTs, CBC, electrolytes
9. Strict glucose monitoring q1h, target 140–180 mg/dL
Treatment if suspicion is encephalitis. Blood glucose is initially 110 , then 70 .
| Step | Action |
|---|---|
| IV access present | D50W 25 mL IV bolus stat, recheck in 15 min |
| No IV access | Glucagon 1 mg IM |
| Maintenance | Start 10% Dextrose infusion (risk of recurrent hypoglycemia from sulfonylurea/insulin) |
| Target glucose | 140–180 mg/dL |
| Monitoring | Recheck glucose every 30–60 minutes |
⚠️ Reassess sensorium after glucose correction — altered consciousness may partially or fully resolve if hypoglycemia was the primary driver.
"Most patients with suspected herpes encephalitis are treated immediately, with the drug discontinued later if the diagnosis is not confirmed." — Plum & Posner
| Drug | Dose | Route | Duration | Notes |
|---|---|---|---|---|
| Acyclovir | 10 mg/kg q8h | IV (over 1 hr) | 14–21 days | Start empirically — do not delay for LP or MRI |
| Ceftriaxone | 2 g q12h | IV | Until bacterial meningitis excluded | Can't clinically distinguish from bacterial meningitis |
| Dexamethasone | 0.15 mg/kg q6h × 4 days | IV | Give before or with first antibiotic dose | Reduces neurological sequelae of bacterial meningitis |
| CrCl (mL/min) | Dose |
|---|---|
| >50 | 10 mg/kg q8h (full) |
| 25–50 | 10 mg/kg q12h |
| 10–25 | 10 mg/kg q24h |
| <10 / dialysis | 5 mg/kg q24h |
Infuse over 1 hour + maintain good hydration → prevents renal crystalline nephropathy.
| Investigation | Purpose |
|---|---|
| Lumbar puncture | HSV-1/2 PCR (gold standard), cell count, glucose, protein, culture |
| MRI brain (FLAIR + DWI + Gad) | Mesiotemporal signal = HSV pattern; more sensitive than CT |
| EEG | Periodic lateralized epileptiform discharges (PLEDs) from temporal lobes = HSV signature; rule out NCSE |
| CSF autoimmune panel | NMDA-R, LGI1 antibodies if HSV PCR negative |
| Issue | Management |
|---|---|
| Raised ICP | HOB 30°, fluid restriction, avoid hypotonic fluids |
| Seizures | Levetiracetam IV; prophylaxis warranted |
| Fever | IV Paracetamol; active cooling if >40°C |
| Airway | Intubate if GCS ≤8 |
| Glycemic control | Insulin infusion, target 140–180; avoid hypoglycemia |
| BP | Avoid abrupt falls — maintain cerebral perfusion pressure |
| DVT | LMWH + compression stockings |
| Timing of acyclovir | Mortality |
|---|---|
| Early (before coma) | ~10% |
| Delayed (comatose at treatment) | Up to 70% |
What all to be sent on lumbar puncture. Dose of acyclovir if weight is 50kg.
10 mg × 50 kg = 500 mg IV every 8 hours (i.e., 500 mg TDS)
| Test | Detects |
|---|---|
| Gram stain + bacterial culture & sensitivity | Bacterial meningitis |
| HSV-1 and HSV-2 PCR | Herpes simplex encephalitis ← most important here |
| VZV PCR | Varicella zoster encephalitis |
| Enterovirus PCR | Enteroviral meningitis/encephalitis |
| CMV PCR | In immunocompromised / elderly |
| EBV PCR | If HSV negative, severe encephalitis |
| TB PCR + AFB smear + culture | If TB meningitis suspected |
| Cryptococcal antigen / India ink | Fungal meningitis (if immunocompromised/diabetic) |
| Test | Normal | HSV encephalitis |
|---|---|---|
| CSF glucose | 2.5–4.5 mmol/L | Usually normal |
| CSF protein | 0.15–0.45 g/L | Elevated |
| CSF : blood glucose ratio | >0.6 | Usually >0.5 (unlike bacterial) |
| Lactate | <3.5 mmol/L | Elevated in bacterial/TB |
| Simultaneous blood glucose | — | Send at same time as LP |
| Test | Finding |
|---|---|
| Total WBC count + differential | HSV: 10–1000 WBC, lymphocytic predominance |
| RBC count | HSV: RBCs often present (hemorrhagic necrosis) — distinguishes from traumatic tap by xanthochromia |
| Xanthochromia | Subarachnoid hemorrhage |
| Cytology (if malignancy suspected) | Leptomeningeal carcinomatosis |
| Test | Indication |
|---|---|
| Anti-NMDA receptor antibodies | Autoimmune encephalitis (if HSV PCR negative) |
| LGI1, CASPR2, AMPA-R antibodies | Autoimmune encephalitis panel |
| Oligoclonal bands | MS, autoimmune CNS disease |
| IgG index | Intrathecal immunoglobulin synthesis |
| VDRL | Neurosyphilis |
| Parameter | Significance |
|---|---|
| Opening pressure | Normal: 10–20 cmH₂O; elevated in encephalitis/meningitis |
| Appearance | Clear = viral; turbid = bacterial; xanthochromic = blood |
| Closing pressure | Document if raised ICP concern |
| Test | Purpose |
|---|---|
| Blood glucose (at time of LP) | For CSF:blood glucose ratio |
| Blood culture × 2 | Concurrent bacteremia |
| Serum NMDA-R antibodies | Autoimmune encephalitis (send both serum + CSF) |
| Serum HSV IgM/IgG | Supportive evidence (less useful acutely than PCR) |
| Bacterial | Viral/HSV | TB | Normal | |
|---|---|---|---|---|
| Appearance | Turbid | Clear | Clear/viscous | Clear |
| WBC | 100–10,000 (neutrophils) | 10–1000 (lymphocytes) | 10–500 (lymphocytes) | <5 |
| Protein | >1 g/L | Mildly elevated | Very elevated | 0.15–0.45 g/L |
| Glucose | Very low (<1.9) | Normal | Low | 2.5–4.5 |
| RBCs | Absent | Present in HSV | Absent | Absent |
| PCR | Gram stain/culture | HSV PCR +ve | AFB/TB PCR | — |
Role of meropenem , vancomycin. Dose of dexamethasone.
"Due to the emergence of penicillin- and cephalosporin-resistant S. pneumoniae, empirical therapy should include a combination of dexamethasone, a third/fourth-generation cephalosporin, and vancomycin, plus acyclovir, as HSV encephalitis is the leading disease in the differential." — Harrison's 22nd Ed.
| Drug | Dose | Frequency |
|---|---|---|
| Vancomycin | 15–20 mg/kg (750–1000 mg for 50 kg patient) | Every 8 hours IV |
| Indication | Reason |
|---|---|
| Cephalosporin allergy (penicillin/cephalosporin hypersensitivity) | Meropenem replaces ceftriaxone |
| Hospital-acquired / post-neurosurgical meningitis | Covers resistant gram-negatives including Pseudomonas aeruginosa, Enterobacter |
| Listeria meningitis | Patient >55 years old, immunocompromised, diabetic — this patient qualifies → Add ampicillin or use meropenem |
| Highly resistant organisms | ESBL-producing gram-negatives |
"Hospital-acquired meningitis, and particularly meningitis following neurosurgical procedures — empirical therapy should include a combination of vancomycin and meropenem." — Harrison's 22nd Ed.
"Patients who have had a recent hospitalization or surgery may benefit from broader coverage with cefepime or meropenem instead of ceftriaxone." — Rosen's Emergency Medicine
| Drug | Dose | Frequency |
|---|---|---|
| Meropenem | 2 g IV | Every 8 hours |
| (Renal adjustment needed if CrCl <51 mL/min) |
"The first dose of steroids should be given with or 20 minutes before initiation of antibiotics in suspected adult bacterial meningitis." — Rosen's Emergency Medicine
| Drug | Dose | Maximum | Frequency | Duration |
|---|---|---|---|---|
| Dexamethasone | 0.15 mg/kg IV | 10 mg per dose | Every 6 hours | 4 days |
0.15 mg × 50 kg = 7.5 mg IV q6h × 4 days (Capped at 10 mg per dose — so 7.5 mg is the correct dose here)
| Situation | Action |
|---|---|
| CSF/blood culture confirms viral (HSV PCR +ve) | Stop dexamethasone |
| Listeria meningitis confirmed | Stop — dexamethasone increases adverse outcomes in Listeria CNS infection |
| Gram-negative meningitis confirmed | Benefit uncertain — discuss with specialist |
| Pneumococcal or H. influenzae confirmed | Continue full 4-day course |
| Drug | Dose (50 kg) | Frequency | Role |
|---|---|---|---|
| Acyclovir | 500 mg IV | q8h × 14–21 days | HSV encephalitis |
| Ceftriaxone | 2 g IV | q12h | S. pneumoniae, N. meningitidis, gram-negatives |
| Vancomycin | 750–1000 mg IV | q8h | Resistant S. pneumoniae |
| Ampicillin | 2 g IV | q4h | Listeria (age >55 + diabetic) |
| Dexamethasone | 7.5 mg IV | q6h × 4 days | Reduce neuroinflammation — give before/with first antibiotic |
Stop/de-escalate based on CSF PCR and culture results within 48–72 hours.
Does meropenem cover listeria and neisserea
"For all ages from 3 months onward, an alternative treatment is meropenem plus vancomycin — does not provide coverage for Listeria." — Adams and Victor's Principles of Neurology, 12th Ed.
| Antibiotic | Covers Listeria? |
|---|---|
| Ampicillin | ✅ Yes — drug of choice |
| Penicillin G | ✅ Yes |
| Trimethoprim-sulfamethoxazole | ✅ Yes (penicillin-allergic patients) |
| Meropenem | ❌ No |
| Ceftriaxone / Cefotaxime | ❌ No |
| Vancomycin | ❌ No |
Listeria is an intrinsically resistant organism to all cephalosporins. Meropenem has in vitro activity against Listeria but is considered clinically unreliable for CNS Listeria infection and is not recommended for this indication.
"The β-lactam antibiotic meropenem is as effective as cefotaxime for meningitis caused by S. pneumoniae, N. meningitidis, and H. influenzae." — Goldman-Cecil Medicine
| Organism | Drug of Choice | Does Meropenem Cover? |
|---|---|---|
| S. pneumoniae | Ceftriaxone + Vancomycin | ✅ Yes |
| N. meningitidis | Ceftriaxone / Penicillin G | ✅ Yes (but not needed) |
| Listeria monocytogenes | Ampicillin | ❌ No — must add Ampicillin |
| H. influenzae | Ceftriaxone | ✅ Yes |
| Pseudomonas (nosocomial) | Meropenem / Ceftazidime | ✅ Yes |
| MRSA | Vancomycin | ❌ No |
Patient has history of vertigo since one year and stuttering of speech.
| Feature | Localisation |
|---|---|
| Vertigo × 1 year | Posterior fossa — vestibular nuclei, cerebellum, or PICA territory (chronic vertebrobasilar insufficiency / TIAs) |
| Dysarthria (stuttering speech) | Brainstem involvement — corticobulbar tracts, cerebellum, or pons |
| Acute altered sensorium / disorientation | Basilar artery territory ischaemia affecting the reticular activating system (RAS) in the midbrain/upper pons |
| Normal CT brain | CT misses 90% of posterior fossa strokes acutely — especially brainstem infarcts |
| Diabetes + Hypertension | Major risk factors for vertebrobasilar atherosclerosis |
| Fever + URTI | Intercurrent illness → haemodynamic stress → precipitating event on a background of chronic vertebrobasilar insufficiency |
"Coma, ataxia, and vertigo, which are common with vertebrobasilar (posterior circulation) stroke, are uncommon with carotid (anterior circulation) stroke." — Bradley and Daroff's Neurology in Clinical Practice
"Vertebrobasilar strokes produce unilateral or bilateral motor/sensory deficits, usually accompanied by cranial nerve and brainstem signs — vertigo, diplopia, ataxia." — Washington Manual of Medical Therapeutics
| Diagnosis | Key Features |
|---|---|
| Acute basilar artery occlusion / brainstem infarct | Vertigo + dysarthria + altered consciousness + risk factors. CT normal — MRI mandatory |
| Vertebrobasilar TIA evolving to stroke | 1 year of recurrent vertigo = prior TIAs in posterior circulation |
| Cerebellar infarct with brainstem compression | CT may miss; causes sudden deterioration |
| Diagnosis | Notes |
|---|---|
| PRES (Posterior Reversible Encephalopathy Syndrome) | Known hypertension + altered sensorium; CT may be normal; MRI shows posterior white matter oedema |
| Wallenberg syndrome (PICA infarct) | Vertigo, dysarthria, dysphagia, ipsilateral facial numbness, Horner's — classic posterior inferior cerebellar artery territory |
| Basilar artery thrombosis | Medical emergency; produces coma, locked-in state, quadriplegia |
| Hypertensive brainstem haemorrhage | CT would show — if not, consider MRI |
| Investigation | Why |
|---|---|
| MRI Brain — DWI sequence | DWI picks up acute ischaemia within minutes to hours; CT misses posterior fossa strokes acutely in up to 90% |
| MRI FLAIR | Detects PRES (posterior white matter oedema), encephalitis |
| MRA (MR Angiography) | Visualises basilar artery, vertebral arteries — detects stenosis/occlusion/dissection |
| T2/GRE | Detects haemorrhage in posterior fossa |
A normal CT does NOT rule out posterior circulation stroke. This is the most common diagnostic pitfall in brainstem infarction.
| Finding | Significance |
|---|---|
| Nystagmus | Brainstem / cerebellar involvement |
| Direction of nystagmus | Horizontal + direction-changing = central (brainstem); purely horizontal + direction-fixed = peripheral |
| Diplopia | CN VI or III palsy — brainstem |
| Dysphagia | Corticobulbar / medullary involvement |
| Ataxia / finger-nose test | Cerebellar hemisphere involvement |
| Crossed signs | Ipsilateral cranial nerve + contralateral limb = brainstem lesion (classic) |
| Horner's syndrome | Lateral medullary (Wallenberg) syndrome |
| Gait | Truncal / gait ataxia = cerebellar vermis |
| Blood pressure both arms | Difference >20 mmHg = subclavian steal / vertebral artery disease |
| HINTS exam | Head Impulse, Nystagmus, Test of Skew — bedside tool to distinguish central vs peripheral vertigo |
| Test | Peripheral (benign) | Central (brainstem — dangerous) |
|---|---|---|
| Head Impulse | Abnormal (corrective saccade) | Normal ← dangerous sign |
| Nystagmus | Unidirectional, horizontal | Direction-changing or vertical |
| Skew deviation | Absent | Present |
A normal head impulse test + direction-changing nystagmus = CENTRAL cause — treat as stroke.
62M + Diabetes + Hypertension
↓
Chronic vertebrobasilar insufficiency
(1 year of recurrent vertigo + dysarthria = posterior circulation TIAs)
↓
Intercurrent viral illness (fever, URTI)
↓
Haemodynamic compromise / plaque rupture
↓
ACUTE BASILAR TERRITORY ISCHAEMIA
= Altered sensorium (RAS involvement)
↓
CT BRAIN NORMAL ← Expected in posterior fossa stroke
↓
MRI BRAIN + MRA URGENTLY
Plantar was normal. No weakness of upper and lower limbs.
| Finding | Interpretation |
|---|---|
| Plantar reflex — normal (flexor) | No corticospinal (pyramidal) tract involvement |
| No upper limb weakness | No motor cortex, internal capsule, or corticospinal tract lesion |
| No lower limb weakness | Rules out hemispheric stroke, cord lesion |
| Symptom | Duration | Significance |
|---|---|---|
| Vertigo | 1 year | Chronic — vestibular or posterior fossa |
| Dysarthria (stuttering) | 1 year | Chronic — cerebellar or extrapyramidal |
| Altered sensorium + disorientation | Acute (1 day) | New — diffuse or specific trigger |
| Fever + running nose | 1 day | Precipitant |
| No focal motor deficit | — | Against acute corticospinal lesion |
| Normal plantar | — | Against pyramidal tract involvement |
| Normal CT | — | Against haemorrhage, large infarct |
| Cause | Clue |
|---|---|
| Cerebellar atrophy (alcohol, age, idiopathic) | Progressive, bilateral — most common |
| Diabetic cerebellar ataxia | Diabetes itself causes cerebellar degeneration |
| Chronic vertebrobasilar insufficiency | Atherosclerosis → repeated small ischaemic insults to cerebellum |
| Paraneoplastic cerebellar degeneration | Rapid onset, anti-Purkinje cell antibodies — needs screening |
| Multiple System Atrophy (MSA-C) | Cerebellar + autonomic features, no motor weakness initially |
| Spinocerebellar ataxia | Genetic; less likely at 62 without family history |
⚠️ If you gave D50W for hypoglycaemia without giving thiamine first — Wernicke's can be precipitated or worsened.
| Investigation | Priority | Reason |
|---|---|---|
| MRI Brain (DWI + FLAIR + T2 + cerebellum cuts) | 🔴 Urgent | CT misses cerebellar lesions, PRES, Wernicke's (mamillary body signal on T1) |
| Serum thiamine level | 🔴 Urgent | Wernicke's |
| IV Thiamine 200–500 mg | 🔴 Give empirically NOW | Before any more dextrose; before MRI — do not wait for level |
| Electrolytes, glucose, renal function | 🔴 Urgent | Metabolic encephalopathy |
| Blood glucose monitoring | 🔴 | Hypoglycaemia recurring |
| Check for nystagmus, ophthalmoplegia | Bedside | Wernicke's triad |
| Check gait and finger-nose test | Bedside | Cerebellar signs |
| MRI cerebellum specifically | Urgent | Cerebellar atrophy, infarct, MSA |
| Anti-Purkinje cell antibodies (anti-Yo, anti-Hu) | Elective | If paraneoplastic suspected |
In any confused patient with diabetes, chronic illness, or poor nutrition — always give thiamine before or with glucose. Glucose load without thiamine precipitates acute Wernicke's encephalopathy by depleting the last reserves of thiamine needed for glucose metabolism.
62M | DM | HTN
Chronic: Vertigo + Dysarthria × 1 year
↓
Cerebellar syndrome (chronic)
[No weakness, No pyramidal signs]
↓
Acute: Fever + Hypoglycaemia + ??Thiamine depletion
↓
Acute decompensation → Altered sensorium + Disorientation
↓
Leading diagnoses:
1. Wernicke's encephalopathy (give thiamine NOW)
2. Metabolic encephalopathy on chronic cerebellar disease
3. PRES (hypertension)
4. Paraneoplastic cerebellar degeneration
↓
MRI Brain (FLAIR, DWI, T1 for mamillary bodies)
+ Thiamine supplementation empirically
He is non alcoholic
"While frequently associated with chronic alcohol misuse, Wernicke-Korsakoff syndrome can occur in any clinical situation that is caused by or causes malnutrition." — Kaplan & Sadock's Comprehensive Textbook of Psychiatry
"A significant number of elderly hospitalized patients have evidence of moderate to severe thiamine deficiency... the disease can be precipitated by giving vitamin-free glucose infusions to chronically malnourished subjects." — Plum and Posner's Diagnosis and Treatment of Stupor and Coma
| Category | Examples relevant to this patient |
|---|---|
| Poor dietary intake | Elderly, diabetic diet restriction, anorexia during febrile illness |
| IV dextrose without thiamine | ⚠️ You gave D50W for hypoglycaemia — this can precipitate Wernicke's |
| Diabetes mellitus | Increased thiamine utilisation; metformin may impair thiamine absorption |
| Chronic illness / hospitalisation | Elderly patients frequently thiamine-deficient on admission |
| Malnutrition | Any cause — not just alcohol |
| Malabsorption | GI disease, gastric surgery |
| Prolonged IV fluids without vitamins | Classic hospital-acquired Wernicke's |
| Chemotherapy, dialysis | Not applicable here but documented causes |
| Feature | Fits |
|---|---|
| Vertigo × 1 year | Cerebellar/vestibular involvement (Wernicke's affects cerebellum, brainstem) |
| Dysarthria × 1 year | Cerebellar dysarthria (scanning speech) — Wernicke's / chronic cerebellar disease |
| No limb weakness | No pyramidal involvement — consistent with Wernicke's |
| Normal plantar | No corticospinal tract lesion |
| Acute confusion / disorientation | Wernicke's encephalopathy — diencephalic involvement |
| Fever + febrile illness | Increases metabolic demand for thiamine → precipitates acute decompensation |
| Hypoglycaemia treated with dextrose | ⚠️ Can precipitate/worsen Wernicke's if thiamine not given simultaneously |
| Diabetic + elderly + chronic illness | Risk factors for thiamine depletion independent of alcohol |
| Non-alcoholic | Does NOT exclude Wernicke's |
| Normal CT | Wernicke's is invisible on CT; MRI (FLAIR/T1) shows mamillary body + periaqueductal signal |
| Priority | Diagnosis |
|---|---|
| 🔴 1 | Wernicke's Encephalopathy (non-alcoholic) — Give thiamine NOW |
| 🔴 2 | Chronic cerebellar disease (vertebrobasilar, idiopathic, diabetic) with acute metabolic decompensation |
| 🔴 3 | PRES (hypertensive encephalopathy) |
| 🟡 4 | Viral encephalitis (fever + URTI still present) |
| 🟡 5 | Paraneoplastic cerebellar degeneration (subacute onset, no motor signs — screen for occult malignancy) |
| 🟡 6 | Multiple System Atrophy — Cerebellar type (MSA-C) |
"Its absorption orally is unreliable in malnourished patients — it must be supplied by IV or IM injection. Prompt diagnosis and treatment is crucial to minimise lasting deficits." — Plum and Posner
| Drug | Dose | Route | Frequency | Duration |
|---|---|---|---|---|
| Thiamine (Vitamin B1) | 200–500 mg | IV (in 100 mL NS over 30 min) | TDS | 3–5 days, then oral |
| Sign | How to test |
|---|---|
| Nystagmus | Observe gaze in all directions |
| Ophthalmoplegia | Ask to follow finger — any restricted eye movement? |
| Lateral gaze palsy (CN VI) | Failure to abduct eye |
| Ataxia | Finger-nose, gait (already have dysarthria — likely cerebellar) |
"Behavioral symptoms can be attributed to Wernicke's disease only when accompanied by nystagmus, oculomotor paralysis, and impaired vestibulo-ocular responses that are subsequently reversed by thiamine treatment." — Plum and Posner
Dose of artesunate if malaria
"Any patient with a change in mental status or repeated seizure in the setting of fulminant malaria has cerebral malaria... caused by Plasmodium falciparum... fever, lethargy, neurologic signs... In adults, nonspecific febrile illness progresses to coma over several days." — Harrison's 22nd Ed.
"Parenteral artesunate reduced severe falciparum malaria mortality by 35% in Asian adults vs quinine. Artesunate is the drug of choice for all patients with severe malaria everywhere." — Harrison's 22nd Ed.
| Timing | Dose | Route |
|---|---|---|
| 0 hours (STAT — loading dose) | 2.4 mg/kg | IV |
| 12 hours | 2.4 mg/kg | IV |
| 24 hours | 2.4 mg/kg | IV |
| Then once daily | 2.4 mg/kg | IV (until oral tolerated) |
2.4 mg × 50 kg = 120 mg IV
| Dose | Amount (50 kg) | Time |
|---|---|---|
| Loading | 120 mg IV | 0 h (STAT) |
| 2nd dose | 120 mg IV | 12 h |
| 3rd dose | 120 mg IV | 24 h |
| Then | 120 mg IV | Once daily until oral possible |
Artesunate is given by IV injection (bolus). Can also be given IM if IV not immediately available.
| Oral regimen | Dose |
|---|---|
| Artemether-lumefantrine | 1.5/9 mg/kg BD × 3 days (with food) |
| Or Artesunate + partner drug (ACT) | As per local protocol |
Minimum 24 hours of IV artesunate before switching to oral, regardless of clinical improvement.
| Drug | Dose |
|---|---|
| Artemether IM | 3.2 mg/kg stat IM, then 1.6 mg/kg daily |
| Quinine IV (last resort) | 20 mg salt/kg over 4 hrs (loading), then 10 mg/kg over 2–8 hrs every 8 hrs |
Artemether is erratically absorbed IM and does not confer the same survival benefit as artesunate. Quinine has a narrow therapeutic window — risk of hypoglycaemia, QT prolongation, cinchonism.
If patient is from or travelled to Greater Mekong Subregion (Myanmar, Cambodia, Vietnam, Thailand):
| Intervention | Notes |
|---|---|
| Treat hypoglycaemia | Malaria + quinine both cause hypoglycaemia; glucose monitoring essential |
| Broad-spectrum antibiotics | Sepsis and cerebral malaria are clinically indistinguishable — continue antibiotics |
| Anticonvulsants | Seizures common in cerebral malaria — levetiracetam or diazepam |
| Avoid steroids | High-dose glucocorticoids are harmful in cerebral malaria (proven in trials) |
| Avoid mannitol | Shown to be ineffective/harmful in cerebral malaria |
| Dialysis if renal failure | Start early in acute kidney injury |
| Blood transfusion | If haematocrit <20% or Hb <7 g/dL |
⚠️ Steroids are contraindicated in cerebral malaria — unlike bacterial meningitis where dexamethasone is beneficial.
SEVERE / CEREBRAL MALARIA
Drug of choice: IV Artesunate
50 kg patient:
→ 120 mg IV STAT (0h)
→ 120 mg IV at 12h
→ 120 mg IV at 24h
→ 120 mg IV once daily until oral tolerated
Then switch to oral ACT (artemether-lumefantrine)
DO NOT use steroids
DO correct hypoglycaemia
DO add broad-spectrum antibiotics